Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical data trend for Huons Co's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Huons Co's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Huons Co OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Huons Co's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Huons Co's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Huons Co (XKRX:243070) has a OCF Margin % of 0.00% as of Jun. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Huons Co and its competitors. Over the past decade, Huons Co's OCF Margin % has ranged from 6.36 to 17.12. According to the industry distribution chart, Huons Co ranks #522 out of 960 companies in the Drug Manufacturers industry, placing it in the top 54.4%.
Is Huons Co's OCF Margin % too high?
Huons Co's current OCF Margin % is 0.00%. Over the past 10 years, this metric has ranged from a low of 6.36 to a high of 17.12. Based on the distribution chart, Huons Co ranks #522 out of 960 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Huons Co has a GF Score™ of 87/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Huons Co's OCF Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Huons Co ranks #522 out of 960 companies for OCF Margin %. This places Huons Co in the lower half of its industry. The industry median OCF Margin % is 9.75. Historically, Huons Co's own OCF Margin % has ranged from 6.36 to 17.12 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.75, based on 960 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Huons Co and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Huons Co's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Huons Co stock overvalued right now?
Based on GuruFocus' analysis, Huons Co (XKRX:243070) is currently considered Modestly Undervalued. The stock's GF Value™ is ₩31,317.35, compared to a current price of ₩24,900.00 — trading 20.5% below its estimated fair value. The current OCF Margin % is 0.00%. Huons Co's overall GF Score™ is 87/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Huons Co (XKRX:243070), the current OCF Margin % is 0.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Huons Co (XKRX:243070) Overvalued in 2026?
Based on GuruFocus' analysis, Huons Co stock appears to be undervalued.
The current stock price of ₩24,900.00 is trading 20.5% below its estimated GF Value™ of ₩31,317.35.
GuruFocus considers Huons Co to be Modestly Undervalued.
Key valuation signals for XKRX:243070:
OCF Margin %: 0.00%
GF Value™: ₩31,317.35 vs. price of ₩24,900.00 (20.5% below fair value)
No single metric tells the full story. See the XKRX:243070 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Huons Co Ltd is a Korean company. It is engaged in the manufacture and distribution of pharmaceutical products. The company produces pharmaceutical products including parenteral injections such as lidocaines, merit C injections; tablets such as phentermine, diet pills, and capsules such as Daisen and Fuxetine and other ethical and over-the-counter drugs. It also produces ampoules, vials, cartridges, and caps for use of medicals, foods, and cosmetics.
87GF Score
Get the complete analysis for XKRX:243070
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKRX:243070 has been successfully added to your 
